CRDO · Credo Technology Group

Credo Technology Group Holding Ltd [CRDO]

Tier-2 memo · 2026-07-29 · spot $192.28 · $35.9bn market cap · AI-datacentre interconnect (AECs, SerDes, optical)

12-month target
$238
+23.6% to spot · bear $123 · bull $376
Implied path requires
45.2%
5y revenue CAGR → $8.6bn FY2031
Demonstrated (trailing 3y)
93.5%
margin +48.3pp
Demonstrated (run-rate)
33.8%
margin −11.4pp
Top 3 end customers
84%
of FY2026 revenue · top 10 ≈ 90%
Contracted backlog
$31.9m
2.4% of annual revenue
This memo issues no position verdict. It scores Criteria and outputs an analysis. The book decides.

The finding

The screen's +37.2pp valuation margin compares a required 56.3% five-year CAGR against a trailing 93.5% three-year CAGR. The trailing number is one extraordinary year (+205.7% in FY2026, off a $184m base) wearing a three-year label — the same window contains FY2024 at +4.8%. Measured against the rate Credo is currently compounding at, the margin is negative.

QuarterRevenueSequentialYear-on-year
Q3 FY2026 (2026-01-31)$407.0m+51.9%+201.5%
Q4 FY2026 (2026-05-02)$437.0m+7.4%+157.0%
Q1 FY2027 (guided)$465–475m+7.6%+110.7%

Management pre-announced this itself on 2026-02-09: "Credo expects sequential revenue growth in the mid-single digits." A sustained 7.5% sequential rate annualises to 33.8%.

What the accounting-quality work found

The growth is real. Cleaner than any precedent this framework was built on. FY2026 revenue tripled to $1,335.1m and the MD&A states that AEC volume at hyperscale data-centre customers contributed "over 99% of the increase in revenue." Days sales outstanding fell from 109.5 to 48.6. Operating cash flow was $464.3m against $472.3m of net income. The year's acquisitions were declared immaterial with no pro-forma required. No settlement revenue, no milestone lumpiness, no channel stuffing.

Three qualifications, all documented in filings: the customer-warrant contra revenue of $13.2m in FY2025 falling to zero in FY2026 flatters the acceleration by ~9pp; the IP-licence revenue split was disclosed for three years and then withdrawn (though it was only 3% of FY2025, so it cannot hide much); and inventory rose +20.6% sequentially in Q4 against +7.4% revenue growth, to 164 days.

Concentration, and the correction that already happened

Three end customers are 84% of FY2026 revenue (33% / 32% / 19%); one direct customer is 53% of receivables; the top ten are ~90%. Contracted backlog is $31.9m against $1,335m of revenue, and orders are cancellable on short notice without penalty.

In FY2023 one end customer was 55% of revenue. In FY2024 it was 26% — roughly $101m to $50m. Quarterly revenue fell 40.9% sequentially and the full year grew 4.8%. That is not a modelled downside case; it is Credo's own three-year-old history, and the same 50% cut applied to today's largest customer removes ~16% of revenue.

The screen input that was wrong

Net cash was overstated by $770m (53%). The 10-K's subsequent-events note discloses that DustPhotonics closed in May 2026 for $770m cash, after the 2026-05-02 balance-sheet date. Corrected net cash is ~$673.3m; EV/Sales rises from 25.7x to 27.1x and required CAGR from 56.3% to 58.0% on the screen's own other parameters. Share count, TTM revenue, margins and the EPS cross-check all verified correct.

The management-revealed cross-check

The CEO's May-2026 performance share units carry six revenue hurdles from $2.5bn to $7.5bn over a five-year period ending 2031-06-30. The base implied path requires $8.6bn of FY2031 revenue — 15% above the maximum-payout tranche of management's own incentive ladder. On the screen's uncorrected parameters it requires $12.5bn, 66% above it. The board also attached a $489.40 stock-price hurdle to that top tranche, 2.55x spot — so the same document cuts both ways, and both cuts are in the valuation.

Criteria

CriteriaTypeResult
QualityBINDINGPASS — COMPOUNDER; demerits: SBC 13.7% of revenue, dilution
Valuation (implied path)BINDINGPASS WITH ARGUMENT — named, dated, quantified
LiquidityBINDINGPASS — $1.9bn/day; Jan-2027 option chain only
DownsideMEASUREDNamed cause with a realised precedent; 30% in 8 quarters
MomentumMEASURED12-1 +135.1%, 1-month −19.2% — deteriorating
CatalystMEASUREDQ1 FY2027 print decides it (~early Sept 2026, estimated)
ConsensusMEASUREDINDETERMINATE — Alpha Vantage quota exhausted; blocks nothing
Short MechanismMEASUREDFires on both legs; logged for the RV fork
Peer SpreadMEASUREDALAB ~44x vs CRDO 25.6x vs MRVL 17.7x EV/TTM sales
Sub-sectorMEASUREDAI-infrastructure semis — correlated with 7 existing corpus names

Read the full analysis